1. Home /
  2. Pharmaceuticals


This Pharma Presents a Potential 'Lose-Win' Situation for Patients and Investors

Two in five Americans are obese. Treatments that target obesity directly could be the next blockbuster pharma category.

Walgreens Could Continue to Weaken

The company reported earnings and the shares have rolled over and turned down.

NovoCure Gaps Sharply Higher for a Breakout: How to Play It

Let's check out the charts and indicators of both NovoCure and Zai Lab.

Teva Pharmaceutical Rallies, So Let's Adjust Our Bullish Strategy

The shares rallied nicely in December.

Acadia Pharmaceuticals Bulls Will Need to Be Patient for Now

The company's charts simply aren't showing sustained strength.

Expect Biotech to Head Higher in 2023

Let's dip into the biotech mailbag as the year comes to an end.

Pfizer May Not Be a Growth Play But It's a Good Stock for Tough Times

PFE is fundamentally sound and certainly not overvalued.

Merck's Stock Could Keep Climbing Higher

Here's what traders should do now.

I'm Going to Give This Biotech Another Shot

Here's a booster for my May Dynavax Technologies trade.

I'm Looking for a Basing Pattern With This Popular Biotech ETF

The charts of this ETF have upside promise, thanks in part to a number of its larger holdings displaying positive-looking charts.